Related Experiment Videos
Vogt-Koyanagi-Harada syndrome
H Hammer1, M Janáky, I Süveges
1Department of Ophthalmology, Albert Szent-Györgyi Medical University, Szeged, Hungary.
Acta Ophthalmologica
|October 1, 1993
Summary
Vogt-Koyanagi-Harada syndrome, an autoimmune condition, was successfully treated in a patient using a combination of low-dose prednisolone and cyclosporine. The treatment targeted demonstrated cellular and humoral hypersensitivity to uveal and retinal antigens.
Area of Science:
- Ophthalmology
- Immunology
- Rheumatology
Background:
- Vogt-Koyanagi-Harada (VKH) syndrome is a multisystem inflammatory disorder primarily affecting the eyes.
- The exact etiology of VKH syndrome remains unclear, but it is believed to involve autoimmune processes.
Observation:
- A case study of a 40-year-old White female diagnosed with Vogt-Koyanagi-Harada syndrome is presented.
- The patient exhibited cellular and humoral hypersensitivity to uveal and retinal antigens.
Findings:
- Successful treatment of VKH syndrome was achieved using a combination therapy.
- The therapeutic regimen included low-dose prednisolone and cyclosporine.
Implications:
- This case highlights the efficacy of combined immunosuppressive therapy in managing VKH syndrome.
- Targeting antigen-specific hypersensitivity may be a key therapeutic strategy for autoimmune uveitis.